T. Marysael

A dual-targeting anticancer approach: soil and seed principle.

Y. Ni, G. Marchal, J. Nuyts, 2011, Radiology.

Exploitation of Necrosis Avidity: from Diagnostics to Theragnostics in Oncology

Y. Ni, G. Marchal, J. Nuyts, 2009 .

Sequential Small Molecular Dual Targeting Theragnostics: A Workable Strategy towards Improved Cancer Treatability or Curability?

Guy Marchal, Huaijun Wang, Johan Nuyts, 2009 .

Pretargeting of necrotic tumors with biotinylated hypericin using 123I-labeled avidin: evaluation of a two-step strategy

Y. Ni, G. Bormans, J. Rozenski, 2012, Investigational New Drugs.

A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

P. Vandenabeele, P. Agostinis, J. Gołąb, 2012, The EMBO journal.

Radiolabeled iodohypericin as tumor necrosis avid tracer: diagnostic and therapeutic potential

Y. Ni, G. Bormans, T. Roskams, 2012, International journal of cancer.

Influence of the vascular damaging agents DMXAA and ZD6126 on hypericin distribution and accumulation in RIF-1 tumors

Y. Ni, E. Lerut, P. Witte, 2011, Journal of Cancer Research and Clinical Oncology.

A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

P. Vandenabeele, P. Agostinis, J. Gołąb, 2012, The EMBO journal.